NCT02307461View on ClinicalTrials.gov

Bioequivalence of Duvelisib and Food Effect on Pharmacokinetics of IPI-145

PHASE1CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

September 30, 2015

Conditions
Healthy
Interventions
DRUG

IPI-145 (duvelisib)

High single oral dose capsule IPI-145 test formulation and IPI-145 reference formulation (capsule) high single oral dose

DRUG

IPI-145

Low single oral dose capsule IPI-145 test formulation and IPI-145 reference formulation (capsule) low single oral dose

DRUG

IPI-145

High single oral dose IPI-145 test formulation (capsule) with a high-fat meal and without food

Trial Locations (1)

66219

Lenexa

All Listed Sponsors
lead

SecuraBio

INDUSTRY

NCT02307461 - Bioequivalence of Duvelisib and Food Effect on Pharmacokinetics of IPI-145 | Biotech Hunter | Biotech Hunter